Vor Biopharma (VOR) Accumulated Depreciation (2020 - 2026)

Vor Biopharma (VOR) has 7 years of Accumulated Depreciation data on file, last reported at $53000.0 in Q1 2026.

• Quarterly Accumulated Depreciation fell 99.56% year-over-year to $53000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $53000.0 (down 99.56% YoY) and the FY2025 annual result came in at $25000.0, down 99.78% from the prior year.
• Accumulated Depreciation advanced to $53000.0 in Q1 2026 per VOR's latest filing, from $25000.0 in the prior quarter.
• Across five years, Accumulated Depreciation topped out at $12.0 million in Q1 2025 and bottomed at $1000.0 in Q3 2025.
• The 5-year median for Accumulated Depreciation is $5.9 million (2023), against an average of $5.9 million.
• The widest annual swing landed in 2022, when Accumulated Depreciation jumped 142.04%; it then slumped 99.99% in 2025.
• Tracing VOR's Accumulated Depreciation over 5 years: stood at $4.6 million in 2022, then soared by 75.51% to $8.1 million in 2023, then surged by 38.6% to $11.2 million in 2024, then plunged by 99.78% to $25000.0 in 2025, then surged by 112.0% to $53000.0 in 2026.
• Per Business Quant, the three latest VOR Accumulated Depreciation figures stand at $53000.0 (Q1 2026), $25000.0 (Q4 2025), and $1000.0 (Q3 2025).

Peer Comparison